Cramer Shares His Thoughts On Anavex Life Sciences, Upstart And More

On CNBC's "Mad Money Lightning Round," Jim Cramer said he is intrigued about Anavex Life Sciences Corp AVXL because Biogen Inc BIIB data doesn't look that good. He sees it as a real spec, but he would stick with it.

Cramer is done with Chinese IPOs. He would sell Nio Inc - ADR NIO.

He doesn't understand a short position in Upstart Holdings Inc UPST.